Product Recalls in North Dakota

Product recalls affecting North Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to North Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,535 recalls have been distributed to North Dakota in the last 12 months.

47,938 total recalls
2,535 in last 12 months

Showing 79217940 of 13,369 recalls

DrugMay 5, 2017· Ascend Laboratories LLC

Recalled Item: AMLODIPINE BESYLATE TABLET Recalled by Ascend Laboratories LLC Due to...

The Issue: PRESENCE OF FOREIGN TABLETS/CAPSULES: A 2.5 mg Amlodipine Besylate tablet...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 5, 2017· Genetic Edge Compounds LLC

Recalled Item: GEC LX Laxoplex 60 capsules Dietary Supplement Recalled by Genetic Edge...

The Issue: Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugMay 2, 2017· Lupin Pharmaceuticals Inc.

Recalled Item: Famotidine for Oral Suspension USP Recalled by Lupin Pharmaceuticals Inc....

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 1, 2017· Allergan Sales, LLC

Recalled Item: Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic...

The Issue: Failed Impurities/Degradation Specifications: stability testing results did...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 28, 2017· PAR Sterile Products LLC

Recalled Item: Buprenorphine HCI Injection Recalled by PAR Sterile Products LLC Due to...

The Issue: Crystallization: due to the presence of white, crystalline particulates,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 27, 2017· Hetero USA Inc

Recalled Item: Acyclovir Tablets Recalled by Hetero USA Inc Due to Presence of Foreign...

The Issue: Presence of Foreign Substance: human hair melded into tablet.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 27, 2017· Noven Pharmaceuticals, Inc.

Recalled Item: Minivelle (estradiol Transdermal System) 0.1 mg per day Recalled by Noven...

The Issue: Defective Delivery System: Out of specification for peel force from the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 24, 2017· Teva Pharmaceuticals USA

Recalled Item: Clozapine Tablets USP Recalled by Teva Pharmaceuticals USA Due to Microbial...

The Issue: Microbial Contamination of Non-Sterile Products

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 21, 2017· Hospira Inc.

Recalled Item: Infant 25% DEXTROSE Injection Recalled by Hospira Inc. Due to Presence of...

The Issue: Presence of Particulate Matter: human hair found within an internal sample...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Labeling: Labeled...

The Issue: Labeling: Labeled Error on Declared Strength; report of a 1000 ct bottle...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Amitriptyline HCL Tablets Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 20, 2017· Akorn, Inc.

Recalled Item: IC-Green (indocyanine green for injection Recalled by Akorn, Inc. Due to...

The Issue: Product is being recalled due to low pH value.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 20, 2017· C. O. Truxton

Recalled Item: Phenobarbital Tablets USP Recalled by C. O. Truxton Due to Mislabeling

The Issue: Labeling: Label Mixup; potentially mislabeled

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 10 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Gentell, Inc

Recalled Item: Shield and Protect Moisture Barrier Cream Recalled by Gentell, Inc Due to...

The Issue: GMP Deviations; product may not meet cGMP requirements

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 20 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 19, 2017· Qualgen

Recalled Item: Estradiol 12.5 mg pellet 99.5% Estradiol USP Recalled by Qualgen Due to CGMP...

The Issue: CGMP deviations- Lack of Quality Assurance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund